Publications by authors named "Barbara Hahn"

Claim this Profile
P
Plasma Supported Deposition of Amorphous Hydrogenated Carbon (a-C:H) on Polyamide 6: Determining Interlayer Completion and Dehydrogenation Effects during Layer Growth.
Torben Schlebrowski, Henriette Lüber, Lucas Beucher, Melanie Fritz, Youssef Benjillali, Barbara Hahn

Polymers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the Influence of Residual Stress on Composite Materials Made of Polyhydroxybutyrate (PHB) and Amorphous Hydrogenated Carbon (a-C:H) Layers: Differences Caused by Single Side and Full Substrate Film Attachment during Plasma Coating.
Torben Schlebrowski, Rachida Ouali, Barbara Hahn, Stefan Wehner, Christian B Fischer

Polymers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refinement of Sustainable Polybutylene Adipate Terephthalate (PBAT) with Amorphous Hydrogenated Carbon Films (a-C:H) Revealing Film Instabilities Influenced by a Thickness-Dependent Change of sp/sp Ratio.
Torben Schlebrowski, Halima Acharchi, Barbara Hahn, Stefan Wehner, Christian B Fischer

Materials (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Must We Embody Context?
Barbara Hahn

Technol Cult· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradox of precision: bright tobacco as technology of transfer, 1880-1937.
Barbara Hahn

Agric Hist· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.
Brian O Porter, Kara B Anthony, Jean Shen, Barbara Hahn, Chris E Keh

AIDS· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness.
Letha M Healey, Barbara K Hahn, Catherine A Rehm, Joseph Adelsberger, Jing Qin

J Interferon Cytokine Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
Douglas Brust, Michael Polis, Richard Davey, Barbara Hahn, Stephen Bacharach

AIDS· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
Chris E Keh, Jean M Shen, Barbara Hahn, Claire W Hallahan, Catherine A Rehm

AIDS· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
Douglas Brust, Michael Polis, Richard Davey, Barbara Hahn, Stephen Bacharach

AIDS· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Barbara M Hahn, Ulrich M H Schrell, Rolf Sauer, Rudolf Fahlbusch, Oliver Ganslandt

J Neurooncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.
Irini Sereti, Hiromi Imamichi, Ven Natarajan, Tomozumi Imamichi, Meena S Ramchandani, Barbara K Hahn

J Clin Invest· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection.
Claire E Farel, Doreen G Chaitt, Barbara K Hahn, Jorge A Tavel, Joseph A Kovacs

Blood· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.
Jorge A Tavel, Irini Sereti, Robert E Walker, Barbara Hahn, Joseph A Kovacs

J Infect Dis· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells.
Irini Sereti, Hector Martinez-Wilson, Julia A Metcalf, Michael W Baseler, Claire W Hallahan, Barbara Hahn

Blood· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis